efficacy of mesotherapy in the treatment of chronic radiculopathy

Efficacy of mesotherapy using drugs versus transcutaneous electrical nerve stimulation (tens) lumbosacral chronic radiculopathy due to disk herniation

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20231203060255N1

Enrollment

Registered

2024-04-09

Start date

2023-10-15

Completion date

Unknown

Last updated

2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic radiculopathy. Radiculopathy, lumbosacral region

Interventions

Intervention 1: Intervention group:2 sessions per week for 3 weeks of mesotherapy for a total of 6 sessions of subcutaneous mesotherapy in acupuncture points related to back pain with 1 ml of piroxica

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1-Consent to participate in the study2- Patients with chronic radicular back pain due to a herniated disc (radicular pain for more than three months and confirming the diagnosis of a herniated disc as the cause of the symptoms by MRI and matching the patient's radicular symptoms with a herniated disc observed in the MRI according to the diagnosis of a physical medicine specialist3- Age above 18 years4- moderate and severe pain intensity (above 5 based on VAS)

Exclusion criteria

Exclusion criteria: 1- Surgery in the last 3 months2- Rheumatological diseases or severe systemic diseases (diabetes,...)3-Neurological diseases (MS, neuropathy,...)4- History of mesotherapy in the last 3 months5- The presence of inflammation in the sacroiliac joint during examinations6- history of fracture in the spine7 presence of spondylolysis or spondylolisthesis8- Coagulation disorders (genetic disorders such as hemophilia or acquired disorders such as warfarin use)9- History of any type of cancer 10- Bone metabolic diseases such as Paget11- Anatomical abnormalities of the spine such as scoliosis12- History of any allergy to the drugs used (allergy to lidocaine or NSAID)13-Kidney failure14- Skin disease at the injection site15- Use of complementary treatments including acupuncture and herbal medicines 1 month before treatment or during treatment16-Drug addiction

Design outcomes

Primary

Measure	Time frame
Pain. Timepoint: Immediately after treatment, one month after treatment, two months after treatment. Method of measurement: Visual Analogue Scale.;Patient function. Timepoint: Immediately after treatment, one month after treatment, two months after treatment. Method of measurement: RMQ (Roland Morris Disability Questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public Contactparisa taheri

Esfahan University of Medical Sciences

Prs_taheri@yahoo.com+98 31 3668 0048

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026